Clinical Trial Update: Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating interferon alfa-2b in patients with advanced low-grade Non-Hodgkin lymphoma; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma
• Small Intestine Cancer

Drugs mentioned

• Interferon alfa-2b (interferon alfa-2b)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lymphoma, Small Intestine Cancer | Phase 2 | Status: COMPLETED